Latest News & Features
Asia-Pacific
Singapore-based Aslan Pharmaceuticals has acquired the full global rights to develop, manufacture and commercialise a cancer treatment. 4 January 2018
Americas
The US Food and Drug Administration revealed additional steps aimed at encouraging generic competition today. 3 January 2018
Americas
AstraZeneca has sold the US rights and New Drug Applications to four drugs to ANI Pharmaceuticals, a speciality pharmaceutical company. 3 January 2018
Americas
The US Court of Appeals for the Federal Circuit has rejected Regeneron’s request for a panel rehearing and rehearing en banc in a case centring on inequitable conduct. 2 January 2018
Americas
Mallinckrodt has revealed plans to acquire biopharmaceutical company Sucampo Pharmaceuticals for $1.2 billion. 2 January 2018
Biotechnology
The UK’s most prolific inventor for 2017 has been named as Alex Powlesland, a research chemist at British biotech company Immunocore. 22 December 2017
Asia
Médecins Sans Frontières has challenged a patent application filed by Gilead in China, claiming that the rejection of the patent would “pave the way towards the availability of affordable generic versions”. 21 December 2017
Big Pharma
France’s competition regulator has fined Johnson & Johnson and its subsidiary Janssen-Cilag €25 million for delaying generic versions of the pain drug Durogesic. 21 December 2017
Americas
Shire is attempting to secure a preliminary injunction against two of Roche’s subsidiaries, Genentech and Chugai Pharmaceutical. 20 December 2017
Americas
The US Patent Trial and Appeal Board has instituted inter partes reviews of two patents owned by Sanofi covering Lantus (insulin glargine injection). 20 December 2017